Dendreon Corp. Message Board
-
This movement is interesting!!!
Sentiment: Strong Buy
-
He knows about technology and may agree it would have been a waste to build spectrum to nowhere and have respect for our regard for future small cell technology!!!
Sentiment: Strong Buy
-
I think he may!!!
FCC Nominee to Divest AT&T, Verizon to Avoid ConflictSentiment: Strong Buy
-
The first time we see a human tumor shrinking is when bidders will come in!!!
Sentiment: Strong Buy
-
-
a tumor shrinking in the Mary Crowley ONT-10 study!!! And that news doesn't have to wait til the end of the year, does it?
Sentiment: Strong Buy
-
Google this
treilly123 wrote: I've started a phase 1 clinical trial for a cancer vaccine drug. It is called ONT-10 and targets a protein called MUC1 that is ...
Looks like the ONT-10 was edited out. This original header states ONT-10 but if you look below the message it says it was edited once by the writer on Dec 18th. I wonder if someone asked her to not mention the name???Sentiment: Strong Buy
-
Because after they pay us for our patent they will become a legitimate search engine
Sentiment: Strong Buy
-
4.05
-
no it won't at 8:00 am it will bid at yesterday's close!!!
Sentiment: Strong Buy
-
someone got a nice 3500 shares cheap this morning
Sentiment: Strong Buy
- Reply to
For newbies who want to know the depth of this company. Read this
by sayertruth79 •May 15, 2013 7:20 AMread the BNA version
Sentiment: Strong Buy
-
Google this headline!!!
FiberTower Injunction Raises Fresh Questions About the Interplay Between
Telecommunications and Bankruptcy LawSentiment: Strong Buy
-
in a bull run kill your stops now!!!
-
type in ont-10 in the search line of the Colon Club messages. Ont-10 is our future.
-
it is doing well
-
when will jury come back??? hahahttp://finance.yahoo.com/mb/forumview/?&bn=335d0cab-c8c2-325a-b1c7-5bd038d7c88f#
-
why such a large buy in at the market?
-
some believe they are on it and being helped. they claim very low side effects as well!!!
Sentiment: Strong Buy
-
The Colon Club • View topic - my immunotherapy trial... update jan ...
Sentiment: Strong Buy